Abstract | OBJECTIVE: PATIENTS AND METHODS: RESULTS: The cholesterol level before RIT with rhTSH was significantly lower than that after RIT with rhTSH (P<0.001). The cholesterol level increased before RIT with THW and decreased to within a normal range after RIT with THW (P<0.001). AST and ALT levels before RIT with THW were significantly higher than those before RIT with rhTSH (P<0.001). The serum Cr level before RIT with THW was higher than that before RIT with rhTSH (P<0.001). No significant differences in the serum values of AST, ALT, and Cr after RIT were observed between the THW and rhTSH groups. The remaining iodine was used to estimate radioiodine clearance and renal function indirectly. In 72 patients treated with the same activity of I for THW and rhTSH, the mean counts of regions of interest in the rhTSH group were significantly lower than those in the THW group (P<0.001). CONCLUSION:
rhTSH administration can sustain liver and renal function in thyroid cancer patients during RIT. Moreover, the use of rhTSH reduces unnecessary radiation exposure.
|
Authors | Soo Jin Lee, Ho-Young Lee, Won Woo Lee, Sang Eun Kim |
Journal | Nuclear medicine communications
(Nucl Med Commun)
Vol. 35
Issue 7
Pg. 727-32
(Jul 2014)
ISSN: 1473-5628 [Electronic] England |
PMID | 24709982
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Iodine Radioisotopes
- Recombinant Proteins
- Thyrotropin
- Cholesterol
|
Topics |
- Adolescent
- Adult
- Aged
- Cholesterol
(metabolism)
- Humans
- Iodine Radioisotopes
(adverse effects, pharmacokinetics, therapeutic use)
- Kidney
(drug effects, physiology, radiation effects)
- Kidney Function Tests
- Liver
(drug effects, physiology, radiation effects)
- Liver Function Tests
- Male
- Middle Aged
- Recombinant Proteins
(pharmacology)
- Retrospective Studies
- Thyroid Neoplasms
(metabolism, physiopathology, radiotherapy)
- Thyrotropin
(pharmacology)
- Young Adult
|